Circulating fetal and total cell-free DNA, and sHLA-G in black South African women with gestational hypertension and pre-eclampsia

Pre-eclampsia

(2016) Ben W J Mol et al.   LANCET

Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study

(2016) Radwa Marawan AbdelHalim et al.   Molecular Diagnosis & Therapy

Similarities and differences between the risk factors for gestational hypertension and preeclampsia: A population based cohort study in south China

(2016) Xun Li et al.   Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health

Unknown

(2016)   TRANSFUSION

The hypertensive disorders of pregnancy (29.3)

(2015) Laura A. Magee et al.   BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY

Human leukocyte antigen (HLA)-G during pregnancy part I: Correlations between maternal soluble HLA-G at midterm, at term, and umbilical cord blood soluble HLA-G at term

(2015) Louise Klitkou et al.   HUMAN IMMUNOLOGY

Quantification and Application of Potential Epigenetic Markers in Maternal Plasma of Pregnancies with Hypertensive Disorders

(2015) Hyun Kim et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Prospective evaluation of RASSF1A cell-free DNA as a biomarker of pre-eclampsia

(2015) Francesca Salvianti et al.   PLACENTA

Maternal Genotype and Severe Preeclampsia: A HuGE Review

(2014) Fiona M. Fong et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Cell-free Fetal DNA — A Trigger for Parturition

(2014) Mark Phillippe   NEW ENGLAND JOURNAL OF MEDICINE

Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy

(2014) Laura A. Magee et al.   Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health

The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP

(2014) A.L. Tranquilli et al.   Pregnancy Hypertension-An International Journal of Womens Cardiovascular Health

New Developments in the Pathogenesis of Preeclampsia

(2013) Mihran V. Naljayan et al.   ADVANCES IN CHRONIC KIDNEY DISEASE

Placental Disease and the Maternal Syndrome of Preeclampsia: Missing Links?

(2013) Dionne Tannetta et al.   CURRENT HYPERTENSION REPORTS

Redefining Preeclampsia Using Placenta-Derived Biomarkers

(2013) Anne Cathrine Staff et al.   HYPERTENSION

Review: Cell-free fetal DNA in the maternal circulation as an indication of placental health and disease

(2013) E.S. Taglauer et al.   PLACENTA

The concentrations of soluble HLA-G protein are elevated during mid-gestation and decreased in pre-eclampsia

(2012) Dorota Darmochwal-Kolarz et al.   FOLIA HISTOCHEMICA ET CYTOBIOLOGICA

Evaluation of a Novel Assay for Detection of the Fetal Marker RASSF1A: Facilitating Improved Diagnostic Reliability of Noninvasive Prenatal Diagnosis

(2012) Helen E. White et al.   PLoS One

Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy

(2011) Jennifer A. Hutcheon et al.   BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY

Maternal deaths associated with hypertension in South Africa : lessons to learn from the Saving Mothers report, 2005-2007

(2011) J. Moodley   Cardiovascular Journal of Africa

The severity of clinical manifestations in preeclampsia correlates with the amount of placental infarction

(2010) MARIE-THERESE VINNARS et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

Prospective Study of Placental Angiogenic Factors and Maternal Vascular Function Before and After Preeclampsia and Gestational Hypertension

(2010) Muna Noori et al.   CIRCULATION

Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction

(2009) Medhat S. Alberry et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

The placenta in pre-eclampsia and intrauterine growth restriction

(2008) D J Roberts et al.   JOURNAL OF CLINICAL PATHOLOGY